WT
AEGR

Whittier Trust’s Aegerion Pharmaceuticals AEGR Stock Holding History

Whittier Trust’s Portfolio AEGR Stock Details AEGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-19,314
Closed -$645K – 1113
2014
Q3 		$645K Hold
19,314
– – 0.03% 302
2014
Q2 		$620K Hold
19,314
– – 0.03% 305
2014
Q1 		$892K Buy
19,314
+2,590
+15% +$152K 0.05% 259
2013
Q4 		$1.19M Hold
16,724
– – 0.06% 214
2013
Q3 		$1.43M Sell
16,724
-9,080
-35% -$770K 0.08% 185
2013
Q2 		$1.63M Buy
+25,804
New +$1.37M 0.09% 168

Other funds holding AEGR

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Whittier Trust's AEGR Position: Q4 2014 in Review

Whittier Trust sold out of Aegerion Pharmaceuticals (AEGR) in Q4 2014, closing a stake of 19,314 shares — an estimated $645K sold.

Whittier Trust first reported a position in AEGR in Q2 2013 and held it in 6 quarters. The position peaked at $1.63M in Q2 2013. 95 funds tracked by Wall St. Rank hold AEGR as of Q4 2014.

  • Whittier Trust reported no remaining Aegerion Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
  • Whittier Trust sold 19,314 Aegerion Pharmaceuticals shares in Q4 2014, an estimated $645K.
  • Whittier Trust first reported a position in Aegerion Pharmaceuticals in Q2 2013 and held it in 6 quarters.
  • Whittier Trust's Aegerion Pharmaceuticals position peaked at $1.63M in Q2 2013.
  • 95 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q4 2014.

Based on Whittier Trust's 13F filing for Q4 2014, filed 4 Feb 2015.